Skip to main content
A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers
Press release - First blood test to diagnose bipolar disorder
ALCEDIAG presenting at 2022 World Congress of Psychiatric Genetics
ALCEDIAG Announces the Inclusion of the First Patient in clinical validation study for EDIT-B test: an aid for differential diagnosis of bipolar disorder, based on RNA editing blood biomarkers
On World Bipolar Day ALCEDIAG announces EIT Health supported EDIT-B Consortium validating innovative blood diagnostic test for bipolar disorder
